Evidence map›Paper›PMID 40002292›Full record

ArticleCancers2025

Therapy Combining Sorafenib and Natural Killer Cells for Hepatocellular Carcinoma: Insights from Magnetic Resonance Imaging and Histological Analyses.

Zigeng Zhang, Guangbo Yu, Aydin Eresen, Qiaoming Hou, Sha Webster, Farideh Amirrad, Surya Nauli, Zhuoli Zhang

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zigeng ZhangDepartment of Radiological Sciences, University of California Irvine, Irvine, CA 92617, USA.
Guangbo YuDepartment of Biomedical Engineering, University of California Irvine, Irvine, CA 92617, USA.
Aydin EresenDepartment of Radiological Sciences, University of California Irvine, Irvine, CA 92617, USA.
Qiaoming HouDepartment of Radiological Sciences, University of California Irvine, Irvine, CA 92617, USA.
Sha WebsterDepartment of Biomedical and Pharmaceutical Sciences, Harry and Diane Rinker Health Science Campus, Chapman University, Irvine, CA 92618, USA.ORCID 0000-0002-9997-9081
Farideh AmirradDepartment of Biomedical and Pharmaceutical Sciences, Harry and Diane Rinker Health Science Campus, Chapman University, Irvine, CA 92618, USA.
Surya NauliDepartment of Biomedical and Pharmaceutical Sciences, Harry and Diane Rinker Health Science Campus, Chapman University, Irvine, CA 92618, USA.
Zhuoli ZhangDepartment of Radiological Sciences, University of California Irvine, Irvine, CA 92617, USA.

Funding

MRI-Guided Dendritic-Cell-Based Vaccine Immunotherapy for Pancreatic CancerR01CA209886 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Vahid Yaghmai, Zhuoli Zhang · 2016 to 2026
$3.3M
Image-guided Interventional Combination Liver Cancer ImmunotherapyR01CA241532 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI YAGHMAI, VAHID, ZHANG, ZHUOLI · 2020 to 2024
$1.8M
NCI NIH HHS R01 CA209886NCI NIH HHS R01 CA241532
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

combination therapyhepatocellular carcinoma (HCC)magnetic resonance imaging (MRI)natural killer (NK) cellssorafenibtumor fibrosis

Identifiers

PMID40002292
PMCPMC11853247

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.